Teladoc Health Inc vs T1 Energy Inc. Common Stock — how do they compare? Teladoc Health Inc trades at $5.79 (market cap $1.09B), while T1 Energy Inc. Common Stock trades at $2.81 (market cap $946.42M). The key difference: Teladoc Health Inc is the larger of the two by market cap, and Teladoc Health Inc is trading nearer its 52-week high, T1 Energy Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and T1 Energy Inc. Common Stock for 0 Days on average.
| TDOC | TE | |
|---|---|---|
Market Cap | $1.09B | $946.42M |
Volume | 4,279,268 | 12,898,774 |
Sector | Health | Industrials |
52-Week High | $9.72 | $12.04 |
52-Week Low | $4.47 | $2.72 |
Typical Hold Time | 39 Days | 0 Days |
Enterprise Value | $1.35B | $1.72B |
Signals from Pluang's Aura AI — not financial advice
Teladoc Health (TDOC) trades at $5.81, down 1.86% on the day, with a bearish technical signal and mixed quarterly earnings performance. The company maintains strong gross margins at 68.97% but continues to report net losses, with a -7.13% net income margin for 2025. Recent developments include new executive appointments and ongoing legal investigations, while analyst consensus shows 35.71% buy ratings with a $8.83 price target.
TDOC presents a turnaround opportunity with attractive valuation metrics (P/S 0.43, EV/EBITDA 6.28) and positive cash flow from operations, but faces significant execution risks from persistent losses, BetterHelp segment challenges, and legal scrutiny. The stock trades near multi-year lows, offering potential upside if management can stabilize the business and return to profitability.
T1 Energy (TE) trades at $3.16, down 1.56% today, reflecting ongoing investor caution despite a mixed earnings history. The company shows significant revenue growth from $755M in 2025 to $997M in 2026 but remains deeply unprofitable with a -38.49% net margin. Recent news highlights strategic moves toward vertical integration in solar manufacturing and energy storage, including the G2_Austin facility development and new supply agreements, which are central to its growth narrative.
The investment case hinges on execution of vertical integration and policy tailwinds, offering substantial upside to the $8 consensus target, but high execution risk, persistent losses, and regulatory scrutiny present clear dangers. Analyst sentiment is mixed with a Moderate Buy rating, yet the stock's viability depends heavily on future profitability improvements from 2027 onward.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →T1 Energy Inc. manufactures photovoltaic solar modules and cells in US, operating a solar manufacturing facility in Texas acquired from Trina Solar. The company was formerly known as FREYR Battery before rebranding as T1 Energy in 2025 and changing its NYSE ticker from FREY to TE.
Read more on TE →